Advances in itp - therapy and quality of life - a patient survey

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Matzdorff, Axel C ^a   Arnold, Gabriele ^b   Salama, Abdulgabar ^c   Ostermann, Helmut ^d   Eberle, Sonja ^e   Hummler, Simone ^f  

^a Caritasklinik St Theresia ^*  (Germany)

^b Giessen ITP Self Help Group   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e GLAXOSMITHKLINE   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOGLOBULIN; RHESUS D ANTIBODY; RITUXIMAB;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EPISTAXIS; FEMALE; HEALTH SURVEY; HEMATOMA; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; PETECHIA; PHARYNX HEMORRHAGE; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SPLENECTOMY; THROMBOCYTE COUNT; ADOLESCENT; GERMANY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GERMANY; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUALITY OF LIFE; QUESTIONNAIRES; SPLENECTOMY; YOUNG ADULT;

EID: 80855134307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027350     Document Type: Article

References (30)

1. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, et al. (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 98: 436-442.
2. Djulbegovic B, Cohen Y, (2001) The natural history of refractory idiopathic thrombocytopenic purpura. Blood 98: 2282-2283.
3. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A, (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97: 2549-2554.
4. Feudjo-Tepie MA, Robinson NJ, Bennett D, (2008) Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal. J Thromb Haemost 6: 711-712; author reply 713.
5. Segal JB, Powe NR, (2006) Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost 4: 2377-2383.
6. (2003) British Committee for Standards in haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120: 574-596.
7. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, et al. (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88: 3-40.
8. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, et al. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115: 168-186.
9. McMillan R, Durette C, (2004) Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood 104: 956-960.
10. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN, (2004) Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med 140: 112-120.
11. Mathias SD, Gao SK, Miller KL, Cella D, Snyder C, et al. (2008) Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes 6: 13.
12. Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, et al. (2008) Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey. Curr Med Res Opin 24: 2767-2776.
13. Tarantino MD, Mathias SD, Snyder CF, Isitt JJ, Gernsheimer T, et al. (2010) Impact of ITP on physician visits and workplace productivity. Curr Med Res Opin 26: 319-328.
14. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B, (2000) The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 160: 1630-1638.
15. Lacey JV, Penner JA, (1977) Management of idiopathic thrombocytopenic purpura in the adult. Semin Thromb Hemost 3: 160-174.
16. Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, et al. (2008) Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 112: 4003-4008.
17. Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, et al. (2009) Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet 373: 641-648.
18. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, et al. (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 371: 395-403.
19. Matzdorff AGA, Greinacher A, Hiller E, Kiefel V, Müller-Beissenhirtz H, Ostermann H, Rummel M, Sachs UJ, Salama A, (2010) Diagnose und Therapie der Immunthrombozytopenie. Empfehlungen einer gemeinsamen Expertengruppe der DGHO, DGTI und GTH. Onkologie 33: 2-20.
20. Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B, (2005) Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica 90: 829-832.
21. Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, et al. (2009) Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood 114: 4777-4783.
22. Buchanan GR, Adix L, (2002) Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 141: 683-688.
23. Aledort LMLR, Okano GJ, Leveque JA, (2006) Retrospective matched cohort study of immune thrombocytopenic purpura (ITP): complications related to corticosteroid (CS) use. Blood 108.
24. Berti D, Moons P, Dobbels F, Deuson R, Janssens A, et al. (2008) Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: results of a survey of 985 patients. Clin Ther 30: 1540-1552.
25. Love NAZK, Bylund C, Elder M, Ellis LM, Grothey A, Meropol NJ, Paley D, Ravdin PM, Saltz LB, (2009) Adjuvant therapy report card: Patients with stage II/III colon cancer grade their oncologists. J Clin Oncol 27.
26. Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR, (2003) Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 122: 966-974.
27. Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, et al. (2009) Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol 145: 235-244.
28. Godeau B, Porcher R, Fain O, Lefrere F, Fenaux P, et al. (2008) Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood 112: 999-1004.
29. Matzdorff A, Arnold G, (2007) Treatment of chronic immune thrombocytopenic purpura: the patients' perspective. Eur J Haematol 78: 381-388.
30. Baili LKM, Languille L, Bierling P, Godeau B, Michell M, (2009) Impact of Pregnancy On the Course of Immune Thrombocytopenic Purpura: An Observational Study On 44 Cases. Blood 114.